Halper Sadeh LLC, an investor rights law firm, is investigating three companies for potential securities law violations and breaches of fiduciary duties. The investigations concern Arcellx's $115 per share sale to Gilead Sciences, Enhabit's $13.80 per share sale to Kinderhook Industries, and Veris Residential's $19 per share sale to an Affinius Capital-led consortium. The firm is seeking increased consideration and additional disclosures on behalf of shareholders.

Monteverde & Associates PC, a class action securities firm, has announced an investigation into Enhabit Inc. (NYSE: EHAB) regarding its proposed sale to Kinderhook Industries, LLC. Under the transaction terms, Enhabit shareholders are expected to receive $13.80 per share in cash. The firm is questioning whether the deal represents a fair valuation for shareholders.

Throughout the last three months, 5 analysts have evaluated Enhabit (NYSE:EHAB), offering a diverse set of opinions from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 4 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 1 0 0 2M Ago 0 0 0 0 0 3M Ago 1 0 2 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $10.35, a high estimate of $14.00, and a low estimate of $8.50. This current average represents a 24.29% decrease from the previous average price target of $13.67. Exploring Analyst Ratings: An In-Depth Overview In examining recent analyst actions, we gain insights into how financial experts perceive Enhabit. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Whit Mayo Leerink Partners Announces Market Perform $8.50 - Brian Tanquilut Jefferies Lowers Hold $8.75 $14.00 Ryan Langston TD Cowen Lowers Market Perform $11.00 $12.00 A.J. Rice UBS Announces Neutral $9.50 - Brian Tanquilut Jefferies Lowers Buy $14.00 $15.00 Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments ...Full story available on Benzinga.com

Enhabit (EHAB) delivered earnings and revenue surprises of 40% and 2.18%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Surgery Partners (SGRY) delivered earnings and revenue surprises of 42.86% and 1.38%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

During the last three months, 3 analysts shared their evaluations of Enhabit (NYSE:EHAB), revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 2 0 0 Last 30D 0 0 1 0 0 1M Ago 1 0 1 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 0 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $11.5, a high estimate of $14.00, and a low estimate of $9.50. Experiencing a 14.81% decline, the current average is now lower than the previous average price target of $13.50. Interpreting Analyst Ratings: A Closer Look A comprehensive examination of how financial experts perceive Enhabit is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Ryan Langston TD Cowen Lowers Market Perform $11.00 $12.00 A.J. Rice UBS Announces Neutral $9.50 - Brian Tanquilut Jefferies Lowers Buy $14.00 $15.00 Key Insights: Action Taken: Analysts respond to changes in market ...Full story available on Benzinga.com

Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results. HighPeak Energy posted GAAP earnings of 66 cents per share, versus market estimates of 65 cents per share. The company’s quarterly sales came in at $301.153 million versus expectations of $339.525 million. HighPeak Energy shares declined 15.3% to $13.49 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares jumped 404% to $11.65 after the company announced the launch of Lytus Cloud. CERo Therapeutics Holdings, Inc. (NASDAQ: CERO) gained 167% to $6.81. CERo Therapeutics announced the publication in clinical cancer research a paper titled "Therapeutic Targeting of TIM-4-L With Engineered T CellsFor Acute Myeloid Leukemia." Brera Holdings PLC (NASDAQ: BREA) shares climbed 97.5% to $2.0150 after the company announced that its Executive Chairman, Daniel McClory, acquired a majority stake in the company. Grom Social Enterprises, Inc. (NASDAQ: GROM) gained 88.3% to $1.45. The company announced that it entered into a non-binding letter of intent to acquire Arctic7. Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) rose 43% to $6.83. Creative Medical Technology announces FDA authorization for groundbreaking Type 1 diabetes prevention therapy under expanded access. Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) gained 40.5% to $8.35 after the company received FDA Breakthrough Therapy Designation for its MM120 program in generalized anxiety disorder. The company also announced 12-week durability data from its Phase 2B study of MM120. ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) jumped 34.2% to $2.1601 after the company announced that its subsidiary BioStrand developed a Foundation AI Model that uses Large Language Models Stacking and HYFT Technology. Beneficient (NASDAQ: BENF) shares rose 28.7% to $0.1287. Beneficient agreed to the financing of liquidity transactions for three separate funds managed by ff Venture Capital. MoneyLion Inc. (NYSE: ML) gained 28.3% to $67.43 ...

Enhabit (EHAB) delivered earnings and revenue surprises of -25% and 1.53%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Enhabit (EHAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Icon PLC (ICLR) delivered earnings and revenue surprises of 0.61% and 0.29%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

The company received a waiver for a potential covenant breach with its lenders.

Gainers Vericity, Inc. (NASDAQ: VERY) shares climbed 87.4% to $11.12 after iA Financial Group announced it will acquire the company. POINT Biopharma Global Inc. (NASDAQ: PNT) surged 84.7% to $12.35. Eli Lilly And Co (NYSE: LLY) agreed to acquire POINT Biopharma Global at $12.50 per share in cash, an aggregate of approximately $1.4 billion. ALX Oncology Holdings Inc. (NASDAQ: ALXO) shares jumped 56% to $7.50 after the company released interim Phase 2 data from its ASPEN-06 trial of evorpacept in advanced HER2-positive gastric cancer. SeaStar Medical Holding Corporation (NASDAQ: ICU) gained 53.3% to $0.6398 after jumping 58% on Monday. SeaStar Medical was recently granted Breakthrough Device Designation by the FDA for its Selective Cytopheretic Device for Cardiorenal Syndrome. VIQ Solutions Inc. (NASDAQ: VQS) shares jumped 52% to $0.1991 after falling 18% on Monday. VIQ Solutions recently announced delisting from the Nasdaq. SciSparc Ltd. (NASDAQ: SPRC) shares gained 48.3% to $5.46 after the company announced it was granted a European patent for its core technology. Molekule Group, Inc. (NASDAQ: MKUL) shares climbed 43.6% to $0.2140. MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 41.3% to $0.2827 after falling around 7% on Monday. Delta Apparel, Inc. (NYSE: DLA) shares jumped 19.8% to $7.89 after the company said it received an unsolicited offer to purchase its Salt Life business. Rite Aid Corporation (NYSE: RAD) rose 15.6% to $0.5436. Rite Aid announced the arrival of Ello Market™ to its shelves. Summit Midstream Partners, LP (NYSE: SMLP) gained 15.4% to $15.75. Summit Midstream Partners expects third-quarter adjusted EBITDA of $70 million, up by 20% from the second quarter. Connexa Sports Technologies Inc. (NASDAQ: CNXA) climbed 14.6% to $3.5999. Adagene Inc. (NASDAQ: